Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as ...
more
Read article at Wikipedia
Monoclonal Antibody
Drug class
Drugs:
Award-Winning Work
Awards Won:
| Year | Award | Award Winner | Notes/Description |
|---|---|---|---|
|
|
Nobel Prize in Physiology or Medicine Winners
- 1981
- 1982
- 1983
- 1984
- 1985
- 1986
- 1987
- 1989
Facts from the Community
From the BioVenturist base
Products involving this technology:
- Rituximab
- Trastuzumab
- Palivizumab
- Adalimumab
- Bevacizumab
- Abciximab
- Omalizumab
- Alemtuzumab
- Muromonab
- Efalizumab
Company involved:
View entire collection »Patents:
- WO 200563817
- WO 200563335
- WO 200563292
- WO 200562955
- WO 200562893
- US 20050152902
- WO 200560999
- WO 200560641
- US 20050142620
- JP 2005172546
Parent Technology:
Includes Technology:
- Murine Monoclonal Antibody
- Human Monoclonal Antibody
- Chimeric Monoclonal Antibody
- Humanized Monoclonal Antibody